Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies

被引:173
|
作者
Barber, Thomas M. [1 ,2 ]
Hanson, Petra [1 ,2 ]
Weickert, Martin O. [1 ,2 ,3 ]
Franks, Stephen [4 ]
机构
[1] Univ Hosp Coventry & Warwickshire, Warwickshire Inst Study Diabet Endocrinol & Metab, Coventry, W Midlands, England
[2] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England
[3] Coventry Univ, Ctr Appl Biol & Exercise Sci, Coventry, W Midlands, England
[4] Imperial Coll London, Inst Reprod Med, London, England
来源
CLINICAL MEDICINE INSIGHTS-REPRODUCTIVE HEALTH | 2019年 / 13卷
关键词
Polycystic ovary syndrome; obesity; metabolism; OBSTRUCTIVE SLEEP-APNEA; EXERCISE TRAINING-PROGRAM; HORMONE-BINDING GLOBULIN; INSULIN-RESISTANCE; VISCERAL FAT; ANOVULATORY WOMEN; BODY-COMPOSITION; WEIGHT-LOSS; METABOLIC DYSFUNCTION; CARDIOMETABOLIC RISK;
D O I
10.1177/1179558119874042
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Polycystic ovary syndrome (PCOS) is a common female condition typified by reproductive. hyperandrogenic, and metabolic features. Polycystic ovary syndrome is a genetic condition, exacerbated by obesity. There is a close link between obesity and PCOS based on epidemiological data, and more recently corroborated through genetic studies. There are many mechanisms mediating the effects of weight-gain and obesity on the development of PCOS. The metabolic effects of insulin resistance and steroidogenic and reproductive effects of hyperinsulinaemia are important mechanisms. Adipokine production by subcutaneous and visceral fat appears to play a part in metabolic function, However, given the complexity of PCOS pathogenesis, it is important also to consider possible effects of PCOS on further weightgain. or at least on hampering attempts at weight-loss and maintenance through lifestyle changes. Possible mediators of these effects include changes in energy expenditure, mental ill health. or physical inactivity. In this brief review. we discuss the main mechanisms that underlie the association between obesity and PCOS, from divergent perspectives of weight-gain contributing to development of PCOS and vice versa. We also consider novel management options for women with obesity and PCOS.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Cardiometabolic risk in polycystic ovary syndrome
    Studen, Katica Bajuk
    Pfeifer, Marija
    ENDOCRINE CONNECTIONS, 2018, 7 (07): : R238 - +
  • [42] Polycystic Ovary Syndrome, Obesity, and Pregnancy
    Joham, Anju E.
    Palomba, Stefano
    Hart, Roger
    SEMINARS IN REPRODUCTIVE MEDICINE, 2016, 34 (02) : 93 - 101
  • [43] Vitamin D in polycystic ovary syndrome: Relationship to obesity and insulin resistance
    Joham, Anju E.
    Teede, Helena J.
    Cassar, Samantha
    Stepto, Nigel K.
    Strauss, Boyd J.
    Harrison, Cheryce L.
    Boyle, Jacqueline
    de Courten, Barbora
    MOLECULAR NUTRITION & FOOD RESEARCH, 2016, 60 (01) : 110 - 118
  • [44] Obesity in Polycystic Ovary Syndrome: Insulin Sensitizing Therapy
    Kathleen M. Hoeger
    Current Obesity Reports, 2012, 1 (4) : 191 - 198
  • [45] Obesity and insulin resistance in women with polycystic ovary syndrome
    Hsu Chun-Sen
    Wu Chien-Hua
    Chiu Wan-Chun
    Lee Ching-Tzu
    Chang Chun-Jen
    Hsu Ming-, I
    GYNECOLOGICAL ENDOCRINOLOGY, 2011, 27 (05) : 300 - 306
  • [46] Brown Adipose Tissue and Novel Management Strategies for Polycystic Ovary Syndrome Therapy
    Zhang, Qiaoli
    Ye, Rongcai
    Zhang, Yuan-Yuan
    Fan, Chen-Chen
    Wang, Jun
    Wang, Shuyu
    Chen, Suwen
    Liu, Xiaowei
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [47] The impact of obesity on reproduction in women with polycystic ovary syndrome
    Pasquali, R.
    Gambineri, A.
    Pagotto, U.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2006, 113 (10) : 1148 - 1159
  • [48] Role of microRNA in the Pathogenesis of Polycystic Ovary Syndrome
    Chen, Zhuo
    Ou, Hanxiao
    Wu, Hongliang
    Wu, Peng
    Mo, Zhongcheng
    DNA AND CELL BIOLOGY, 2019, 38 (08) : 754 - 762
  • [49] An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome
    Glintborg, Dorte
    Andersen, Marianne
    GYNECOLOGICAL ENDOCRINOLOGY, 2010, 26 (04) : 281 - 296
  • [50] Prevalence, pathogenesis and management of prediabetes and type 2 diabetes mellitus in patients with polycystic ovary syndrome
    Sofia Lazaridou
    Konstantinos Dinas
    Konstantinos Tziomalos
    Hormones, 2017, 16 : 373 - 380